Wuhu Huaren Science and Technology Co., Ltd. was founded in Aug, 2006. It is headquartered in Wuhu, Anhui, China, mainly engaged in developing and manufacturing nucleosides, nucleotides and pharmaceutical intermediates. In August 2022, Huaren became a holding subsidiary of Huadong Medicine Co., Ltd.. Making full use of the resources of the mother company, Huaren is able to provide global customers with products and services at higher value with lower cost, higher volume and faster speed.

With decades of experience in R&D and manufacturing of products using chemical synthesis, microbial fermentation and enzymatic process, our nucleosides portfolio has covered the whole value chain for building blocks of oligonulceosides, mRNA and materials for In-vitro Diagnosis, including natural nucleosides, modified nucleosides, protected nucleosides, phosphoramidites and nucleotides. We can create value for customers by offering CXO services for laboratory and commericial products under non-GMP and GMP condition.

Huaren strive to be a worldwide nucleosides&nucleotides platform with recognized R&D and manufacturing capabilities, bringing integrated solutions to the healthcare industry.